Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:00 pm Sale | 2025-09-30 | 13G | Mural Oncology plc MURA | Soleus Capital Master Fund, L.P. | 0 0.000% | -1,323,877![]() (Position Closed) | Filing History |
| 2025-11-07 4:00 pm Sale | 2025-09-30 | 13G | STAAR Surgical Company STAA | Soleus Capital Master Fund, L.P. | 500,000 1.000% | -2,062,893![]() (-80.49%) | Filing History |
| 2025-11-07 4:00 pm Purchase | 2025-09-30 | 13G | NovoCure Limited NVCR | Soleus Capital Master Fund, L.P. | 9,644,872 8.600% | 2,740,570![]() (+39.69%) | Filing History |
| 2025-11-07 4:00 pm Sale | 2025-09-30 | 13G | Surmodics, Inc. SRDX | Soleus Capital Master Fund, L.P. | 0 0.000% | -739,060![]() (Position Closed) | Filing History |
| 2025-08-05 5:00 pm Sale | 2025-06-30 | 13G | UroGen Pharma Ltd. URGN | Soleus Capital Master Fund, L.P. | 2,185,000 4.700% | -140,000![]() (-6.02%) | Filing History |
| 2025-08-05 5:00 pm Sale | 2025-06-30 | 13G | Rigel Pharmaceuticals, Inc. RIGL | Soleus Capital Master Fund, L.P. | 658,145 3.700% | -472,534![]() (-41.79%) | Filing History |
| 2025-08-05 5:00 pm Purchase | 2025-06-30 | 13G | Mural Oncology plc MURA | Soleus Capital Master Fund, L.P. | 1,323,877 7.600% | 243,950![]() (+22.59%) | Filing History |
| 2025-08-05 5:00 pm Sale | 2025-06-30 | 13G | Praxis Precision Medicines, Inc. PRAX | Soleus Capital Master Fund, L.P. | 966,740 4.600% | -51,000![]() (-5.01%) | Filing History |
| 2025-08-05 5:00 pm Purchase | 2025-06-30 | 13G | NeuroPace, Inc. NPCE | Soleus Capital Master Fund, L.P. | 2,303,828 7.000% | 2,303,828![]() (New Position) | Filing History |
| 2025-08-05 5:00 pm Purchase | 2025-06-30 | 13G | NovoCure Limited NVCR | Soleus Capital Master Fund, L.P. | 6,904,302 6.200% | 1,382,888![]() (+25.05%) | Filing History |
| 2025-07-21 4:30 pm Purchase | 2025-07-17 | 13D | ESSA Pharma Inc. EPIX | Soleus Capital Master Fund, L.P. | 4,362,026 9.800% | 2,100,000![]() (+92.84%) | Filing History |
| 2025-06-16 5:00 pm Purchase | 2025-06-13 | 13G | UroGen Pharma Ltd. URGN | Soleus Capital Master Fund, L.P. | 2,325,000 5.000% | 2,325,000![]() (New Position) | Filing History |
| 2025-05-02 5:00 pm Sale | 2025-03-31 | 13G | AxoGen, Inc. AXGN | Soleus Capital Master Fund, L.P. | 1,446,117 3.700% | -1,559,826![]() (-51.89%) | Filing History |
| 2025-04-23 9:45 pm Unchanged | 2025-04-23 | 13D | ESSA Pharma Inc. EPIX | Soleus Capital Master Fund, L.P. | 2,262,026 5.100% | 0 (Unchanged) | Filing History |
| 2025-04-16 5:37 pm Purchase | 2025-04-15 | 13G | Mural Oncology plc MURA | Soleus Capital Master Fund, L.P. | 1,079,927 6.300% | 1,079,927![]() (New Position) | Filing History |
| 2025-04-15 4:46 pm Purchase | 2025-04-15 | 13D | ESSA Pharma Inc. EPIX | Soleus Capital Master Fund, L.P. | 2,262,026 5.100% | 2,262,026![]() (New Position) | Filing History |
| 2025-04-11 7:30 pm Sale | 2025-04-11 | 13D | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 4,801,375 10.400% | -387,501![]() (-7.47%) | Filing History |
| 2025-04-01 5:00 pm Purchase | 2025-03-31 | 13G | NovoCure Limited NVCR | Soleus Capital Master Fund, L.P. | 5,521,414 5.000% | 5,521,414![]() (New Position) | Filing History |
| 2025-03-28 5:09 pm Purchase | 2025-03-26 | 13G | STAAR Surgical Company STAA | Soleus Capital Master Fund, L.P. | 2,562,893 5.200% | 2,562,893![]() (New Position) | Filing History |
| 2025-03-19 5:00 pm Purchase | 2025-03-18 | 13G | Praxis Precision Medicines, Inc. PRAX | Soleus Capital Master Fund, L.P. | 1,017,740 5.000% | 1,017,740![]() (New Position) | Filing History |

